Laura Hamill - Jul 15, 2022 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role
Director
Signature
/s/ Sune Reinholth Nyland, Attorney-in-Fact for Laura Hamill
Stock symbol
YMAB
Transactions as of
Jul 15, 2022
Transactions value $
$0
Form type
4
Date filed
7/19/2022, 01:24 PM
Previous filing
Jun 10, 2022
Next filing
Nov 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction YMAB Non-Employee Stock Option (right to buy) Award $0 +16K $0.00 16K Jul 15, 2022 Common Stock 16K $16.64 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options granted to the Reporting Person as a non-employee director pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
F2 The stock options vest in equal monthly installments during the first year following the date of grant, subject to the Reporting Person's continued service to Y-mAbs Therapeutics, Inc., and are exercisable immediately upon vesting.

Remarks:

Exhibit Index: Exhibit 24 - Power of Attorney for Laura Hamill dated July 15, 2022